480
Participants
Start Date
April 30, 2012
Primary Completion Date
December 31, 2014
Study Completion Date
May 31, 2015
the ginsenoside Rg3
Placebo
The First Affiliated Hospital of Harbin Medical University, Harbin
Zhongshan hospital,Fudan University, Shanghai
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Tongji Hospital,Huazhong University of Science ＆ Technology, Wuhan
Tumor Hospital,Sun Yat-san University, Guangzhou
Huazhong University of Science and Technology
OTHER
Shanghai Zhongshan Hospital
OTHER
Sun Yat-sen University
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
First Affiliated Hospital of Fujian Medical University
OTHER
ShenFeng
OTHER